Quantcast

Latest Janssen Research & Development LLC Stories

2014-12-09 00:20:42

Follow-up data from the Phase 2 PCYC-1104 trial presented at the American Society of Hematology Annual Meeting show sustained efficacy and safety over time SAN FRANCISCO and RARITAN, N.J.,

2014-12-08 20:20:41

IMBRUVICA data presented at the American Society of Hematology Annual Meeting show 79 percent of CLL patients with del 17p were progression-free at 12 months SAN FRANCISCO and RARITAN, N.J.,

2014-11-24 16:25:52

Additionally, Trabectedin Expanded Access Program Now Allows Entry of Eligible Patients with Previously Treated Advanced Soft Tissue Sarcoma, Including those with Liposarcoma and Leiomyosarcoma

2014-11-19 08:29:54

First Long-Acting Treatment to be Used Four Times a Year for Schizophrenia in Adults TITUSVILLE, N.J., Nov.

2014-11-06 12:29:21

- Note: This release corresponds to ASH abstracts 22, 31, 78, 84, 176, 327, 505, 2096, 2312, 3448, 3474, 4454, 4469, 4680 RARITAN, N.J., Nov.

2014-10-28 12:31:13

The Program is Jointly Funded by LLS and Janssen Research & Development, LLC WHITE PLAINS, N.Y., Oct.

2014-10-20 08:32:12

Latest submission seeks approval for additional blood cancer indication RARITAN, N.J., Oct.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.